Impact of Platelet Testing on Presurgical Screening and Implications for Cardiac and Noncardiac Surgical Procedures

American Journal of Cardiology

Volumn 98, Issue 10 SUPPL., 2006, Pages

  Bracey, Arthur W ^a   Grigore, Alina M ^a   Nussmeier, Nancy A ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; EPTIFIBATIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY THROMBOSIS; DECISION MAKING; DIAGNOSTIC TEST; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MORBIDITY; MORTALITY; PLATELET FUNCTION ASSAY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL PATIENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; TREATMENT WITHDRAWAL; UNSTABLE ANGINA PECTORIS;

CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE;

EID: 33750629506     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.09.011     Document Type: Article

References (64)

1. Mongan P.D., Brown R.S., and Thwaites B.K. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anesth Analg 87 (1998) 258-265
2. Wallace E.L., Churchill W.H., Surgenor D.M., An J., Cho G., McGurk S., and Murphy L. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion (Paris) 35 (1995) 802-812
3. Dacey L.J., Munoz J.J., Baribeau Y.R., Johnson E.R., Lahey S.J., Leavitt B.J., Quinn R.D., Nugent W.C., Birkmeyer J.D., O'Connor G.T., and Northern New England Cardiovascular Disease Study Group. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Arch Surg 133 (1998) 442-447
4. Despotis G.J., Filos K.S., Zoys T.N., Hogue C.W., Spitznagel E., and Lappas D.G. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 82 (1996) 13-21
5. Rady M.Y., Ryan T., and Starr N.J. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 26 (1998) 225-235
6. Goodnough L.T., Brecher M.E., Kanter M.H., and AuBuchon J.P. Transfusion medicine: first of two parts-blood transfusion. N Engl J Med 340 (1999) 438-447
7. Spiess B.D., Royston D., Levy J.H., Fitch J., Dietrich W., Body S., Murkin J., and Nadel A. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion (Paris) 44 (2004) 1143-1148
8. Rosen N.R., Bates L.H., and Herod G. Transfusion therapy: improved patient care and resource utilization. Transfusion (Paris) 33 (1993) 341-347
9. Khuri S.F., Wolfe J.A., Josa M., Axford T.C., Szymanski I., Assousa S., Ragno G., Patel M., Silverman A., Park M., and Valeri C.R. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 104 (1992) 94-107
10. Harker L.A., Malpass T.W., Branson H.E., Hessel II E.A., and Slichter S.J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 56 (1980) 824-834
11. Pleym H., Wahba A., Videm V., Asberg A., Lydersen S., Bjella L., Dale O., and Stenseth R. Increased fibrinolysis and platelet activation in elderly patients undergoing coronary bypass surgery. Anesth Analg 102 (2006) 660-667
12. Ray M.J., Walters D.L., Bett N., Cameron J., Wood P., and Aroney C. Point-of-care testing shows clinically relevant variation in the degree of inhibition of platelets by standard-dose abciximab therapy during percutaneous coronary intervention. Catheter Cardiovasc Interv 62 (2004) 150-154
13. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
14. Herbert J.M., Dol F., Bernat A., Falotico R., Lale A., and Savi P. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 80 (1998) 512-518
15. Lauer M.A., Karweit J.A., Cascade E.F., Lin N.D., and Topol E.J. Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997. Am J Cardiol 89 (2002) 924-929
16. Singh M., Lennon R.J., Holmes D.R., Bell M.R., and Rihal C.S. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 40 (2002) 387-393
17. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
18. Levine G.N., Ali M.N., and Schafer A.I. Antithrombotic therapy in patients with acute coronary syndromes. Arch Intern Med 161 (2001) 937-948
19. Ferraris V.A., Ferraris S.P., Joseph O., Wehner P., and Mentzer R.M. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 235 (2002) 820-827
20. Morawski W., Sanak M., Cisowski M., Szczeklik M., Szczeklik W., Dropinski J., Waclawczyk T., Ulczok R., and Bochenek A. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism. J Thorac Cardiovasc Surg 130 (2005) 791-796
21. Avidan M.S., Alcock E.L., Da Fonseca J., Ponte J., Desai J.B., Despotis G.J., and Hunt B.J. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92 (2004) 178-186
22. Forestier F., Coiffic A., Mouton C., Ekouevi D., Chene G., and Janvier G. Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant?. Br J Anaesth 89 (2002) 715-721
23. Ray M.J., Hawson G.A., Just S.J., McLachlan G., and O'Brien M. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 57 (1994) 981-986
24. Chen L., Bracey A.W., Radovancevic R., Cooper J.R., Collard C.D., Vaughn W.K., and Nussmeier N.A. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 128 (2004) 425-431
25. Slaughter T.F., Sreeram G., Sharma A.D., El-Moalem H., East C.J., and Greenberg C.S. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 12 (2001) 85-93
26. Lasne D., Fiemeyer A., Chatellier G., Chammas C., Baron J.F., and Aiach M. A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost 84 (2000) 794-799
27. Wahba A., Sander S., and Birnbaum D.E. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery?. Thorac Cardiovasc Surg 46 (1998) 228-231
28. Shore-Lesserson L., Manspeizer H.E., DePerio M., Francis S., Vela-Cantos F., and Ergin M.A. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88 (1999) 312-319
29. Poston R., Gu J., Manchio J., Lee A., Brown J., Gammie J., White C., and Griffith B.P. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 27 (2005) 584-591
30. Despotis G.J., Levine V., Filos K.S., Santoro S.A., Joist J.H., Spitznagel E., and Goodnough L.T. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology 85 (1996) 1311-1323
31. Ereth M.H., Nuttall G.A., Santrach P.J., Klindworth J.T., Oliver W.C., and Schaff H.V. The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass. Anesthesiology 88 (1998) 962-969
32. Ostrowsky J., Foes J., Warchol M., Tsarovsky G., and Blay J. Plateletworks platelet function test compared to the thromboelastograph for prediction of postoperative outcomes. J Extra Corpor Technol 36 (2004) 149-152
33. Ferraris V.A., Ferraris S.P., Lough F.C., and Berry W.R. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 45 (1988) 71-74
34. Goldman S., Copeland J., Moritz T., Henderson W., Zadina K., Ovitt T., Doherty J., Read R., Chesler E., Sako Y., et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 77 (1988) 1324-1332
35. Goldman S., Copeland J., Moritz T., Henderson W., Zadina K., Ovitt T., Kern K.B., Sethi G., Sharma G.V.R.K., Khuri S., et al. Starting aspirin therapy after operation: effects on early graft patency. Department of Veterans Affairs Cooperative Study Group. Circulation 84 (1991) 520-526
36. Kallis P., Tooze J.A., Talbot S., Cowans D., Bevan D.H., and Treasure T. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss-a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 8 (1994) 404-409
37. Sethi G.K., Copeland J.G., Goldman S., Moritz T., Zadina K., and Henderson W.G. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol 15 (1990) 15-20
38. Karwande S.V., Weksler B.B., Gay W.A., and Subramanian V.A. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis. Ann Thorac Surg 43 (1987) 318-322
39. Mangano D.T. Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
40. Lind S.E. The bleeding time does not predict surgical bleeding. Blood 77 (1991) 2547-2552
41. Lennon M.J., Gibbs N.M., Weightman W.M., McGuire D., and Michalopoulos N. A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients. J Cardiothorac Vasc Anesth 18 (2004) 136-140
42. Carroll R.C., Chavez J.J., Snider C.C., Meyer D.S., and Muenchen R.A. Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. J Lab Clin Med 147 (2006) 197-204
43. Ferraris V.A., Ferraris S.P., Moliterno D.J., Camp P., Walenga J.M., Messmore H.L., Jeske W.P., Edwards F.H., Royston D., Shahian D.M., et al. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 79 (2005) 1454-1461
44. Labarthe B., Theroux P., Angioi M., and Ghitescu M. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. J Am Coll Cardiol 46 (2005) 638-645
45. Fox K.A., Mehta S.R., Peters R., Zhao F., Lakkis N., Gersh B.J., and Yusuf S. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 110 (2004) 1202-1208
46. Gurbel P.A., Samara W.M., and Bliden K.P. Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis. Platelets 15 (2004) 95-99
47. Englberger L., Faeh B., Berdat P.A., Eberli F., Meier B., and Carrel T. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 26 (2004) 96-101
48. Hongo R.H., Ley J., Dick S.E., and Yee R.R. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40 (2002) 231-237
49. Kapetanakis E.I., Medlam D.A., Petro K.R., Haile E., Hill P.C., Dullum M.K., Bafi A.S., Boyce S.W., and Corso P.J. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?. Circulation 113 (2006) 1667-1674
50. Mascelli M.A., Lance E.T., Damaraju L., Wagner C.L., Weisman H.F., and Jordan R.E. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation 97 (1998) 1680-1688
51. Tcheng J.E., Ellis S.G., George B.S., Kereiakes D.J., Kleiman N.S., Talley J.D., Wang A.L., Weisman H.F., Califf R.M., and Topol E.J. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 90 (1994) 1757-1764
52. Turner N.A., Moake J.L., Kamat S.G., Schafer A.I., Kleiman N.S., Jordan R., and McIntire L.V. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation 91 (1995) 1354-1362
53. Lincoff A.M., LeNarz L.A., Despotis G.J., Smith P.K., Booth J.E., Raymond R.E., Sapp S.K., Cabot C.F., Tcheng J.E., Califf R.M., Effron M.B., and Topol E.J. Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. Ann Thorac Surg 70 (2000) 516-526
54. Lemmer J.H., Metzdorff M.T., Krause A.H., Martin M.A., Okies J.E., and Hill J.G. Emergency coronary artery bypass graft surgery in abciximab-treated patients. Ann Thorac Surg 69 (2000) 90-95
55. Gammie J.S., Zenati M., Kormos R.L., Hattler B.G., Wei L.M., Pellegrini R.V., Griffith B.P., and Dyke C.M. Abciximab and excessive bleeding in patients undergoing emergency cardiac operations. Ann Thorac Surg 65 (1998) 465-469
56. Singh M., Nuttall G.A., Ballman K.V., Mullany C.J., Berger P.B., Holmes D.R., and Bell M.R. Effect of abciximab on the outcome of emergency coronary artery bypass grafting after failed percutaneous coronary intervention. Mayo Clin Proc 76 (2001) 784-788
57. Uthoff K., Zehr K.J., Geerling R., Herskowitz A., Cameron D.E., and Reitz B.A. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding. Circulation 90 (1994) II269-II274
58. Marso S.P., Bhatt D.L., Roe M.T., Houghtaling P.L., Labinaz M., Kleiman N.S., Dyke C., Simmoons M.L., Califf R.M., Harrington R.A., Topol E.J., and PURSUIT Investigators. Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. Circulation 102 (2000) 2952-2958
59. Madi A., Plavec M., Nawaz H., and Katz D.L. Peri-operative aspirin can prevent post-operative ischemia and thrombosis. Med Hypotheses 55 (2000) 164-167
60. American Society for Gastrointestinal Endoscopy. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 48 (1998) 672-675
61. Sorbi D., Norton I., Conio M., Balm R., Zinsmeister A., and Gostout C.J. Postpolypectomy lower GI bleeding: descriptive analysis. Gastrointest Endosc 51 (2000) 690-696
62. Russell M.W., and Jobes D. What should we do with aspirin, NSAIDs, and glycoprotein-receptor inhibitors?. Int Anesthesiol Clin 40 (2002) 63-76
63. Strom B.L., Berlin J.A., Kinman J.L., Spitz P.W., Hennessy S., Feldman H., Kimmel S., and Carson J.L. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: a postmarketing surveillance study. JAMA 275 (1996) 376-382
64. Merritt J.C., and Bhatt D.L. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 17 (2004) 21-27